Neuberger Berman Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Neuberger Berman Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$496K	–	1920
2023 Q1	$496K	Hold	50,000	–	–	﹤0.01%	1458
2022 Q4	$499K	Hold	50,000	–	–	﹤0.01%	1457
2022 Q3	$276K	Hold	50,000	–	–	﹤0.01%	1636
2022 Q2	$183K	Hold	50,000	–	–	﹤0.01%	1762
2022 Q1	$303K	Hold	50,000	–	–	﹤0.01%	1697
2021 Q4	$422K	Hold	50,000	–	–	﹤0.01%	1602
2021 Q3	$453K	Hold	50,000	–	–	﹤0.01%	1493
2021 Q2	$405K	Hold	50,000	–	–	﹤0.01%	1523
2021 Q1	$276K	Buy	+50,000	New	+$247K	﹤0.01%	1629

Neuberger Berman Group's APEN Position: Q2 2023 in Review

Neuberger Berman Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 50,000 shares — an estimated $496K sold.

Neuberger Berman Group first reported a position in APEN in Q1 2021 and held it in 9 quarters. The position peaked at $499K in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Neuberger Berman Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Neuberger Berman Group sold 50,000 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $496K.
Neuberger Berman Group first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 9 quarters.
Neuberger Berman Group's Apollo Endosurgery, Inc. position peaked at $499K in Q4 2022.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Neuberger Berman Group's 13F filing for Q2 2023, filed 11 Aug 2023.